AI Funding Tracker: Crusoe's $3.9B Round Tops a Week of Compute Bets
Crusoe closed a $3.9 billion Series F at a $30.9 billion valuation, the largest round in this week's AI funding tracker, which covers 23 deals and capital-markets moves spanning compute, training data, applied software, defence and energy.
The financing landed the same week New York urged towns to charge $1 million per megawatt of data center load. DeepSeek separately flagged a $7.45 billion raise, the period's largest planned financing.
Compute Leads the AI Funding Tracker
Infrastructure absorbed the heaviest capital of the period. Crusoe's Series F closed at $3.9 billion and a $30.9 billion valuation, while Verda raised $189 million at a valuation above $1 billion on a bet that GPU scarcity outlasts rivals' buildout. Inference is repricing fastest: Modal Labs and Baseten are negotiating rounds at roughly $15 billion and $26 billion, tripling and doubling their previous valuations.
Expert data now carries infrastructure pricing. Snorkel AI raised $350 million at $3.5 billion, Micro1 cleared $100 million at $4 billion, an eightfold jump in a year on $500 million in annualized revenue, and Naive AI reached $1.42 billion after $400 million across three rounds by betting on mid-training and reinforcement learning rather than pre-training from scratch.
Applied AI Concentrates in Legal, Health and Enterprise
Legora is seeking $300 million at an $8.5 billion pre-money valuation, a 53% rise in six months on $200 million in ARR. Heidi Health raised $340 million at $900 million, Island took $400 million at $6.4 billion for the enterprise browser, and Hang Ten Systems reached $85 million in seed for outcome-priced enterprise AI.
Defence, Energy and the Public-Market Queue
Hardware ran a parallel track. Tekever's Series D closed at $580 million for a $6.4 billion valuation, EnduroSat raised $205 million to push space data toward $1 per gigabyte, and South Korea's first $350 billion US investment project, a 6.3 GW Texas gas plant costing $22.3 billion, is built to power data centers and chip fabs.
The IPO queue carries the risk in this AI funding tracker. Nscale's filing pairs a $103.4 billion contract backlog with $140.6 million in half-year revenue and a $1.02 billion loss, while Iambic Therapeutics filed an S-1 under IAM to fund three cancer programs. Anthropic cut Claude Opus 5.5 pricing 20% to $4/$20 per million tokens weeks before its Nasdaq debut, and OpenAI answered with two cheaper GPT-6 models.
Policy shaped two more items. Manus targeted $4 billion in a $500 million raise, its first since Beijing blocked Meta's acquisition, and Mirendil's round could reach $1 billion at $5 billion with Kleiner Perkins and a16z weighing a bet on self-improving AI. Google.org and the Gates Foundation committed $100 million to AI tools for 200 million smallholder farmers in Africa and South Asia.
Build-out friction is now measurable. Data center opposition blocked or delayed 45 projects worth $68 billion in Q2 2026, and China's humanoid robot IPO queue is slowing as regulators test whether data center and state joint-venture revenue is real demand. NHTSA is drafting outcome-based driverless vehicle standards backed by a $5 million SAE consortium.
Next period, the tests to watch are the Nscale and Iambic IPO pricings, which will show whether a $103.4 billion backlog and three cancer programs convert contract value into public-market valuation.
Related Articles
- AI Funding Tracker: Two $3B Rounds and Nvidia's $2.5B Stake Set the Pace
- Crusoe $30 billion valuation puts contracted GPU revenue to the test
- AI Funding Tracker: Intel's $20B Raise Leads a Busy Week
✔Human Verified
Researched and cross-referenced against primary sources by the Bytevyte editorial team. This article was generated with the assistance of artificial intelligence and reviewed by the Bytevyte editorial team.